Estrogen and progesterone dependent expression of visfatin/NAMPT regulates proliferation and apoptosis in mice uterus during estrous cycle

• Published in: The Journal of steroid biochemistry and molecular biology 2019-01, Vol.185, p.225-236
• Main Authors: Annie, Lalrawngbawli, Gurusubramanian, Guruswami, Roy, Vikas Kumar
• Format: Article
• Language: English
• Subjects: Acrylamides - pharmacology; Animals; Antioxidants; Apoptosis; Apoptosis - physiology; Bax protein; bcl-2-Associated X Protein - biosynthesis; Caspase 3 - biosynthesis; Catalase; Catalase - biosynthesis; Cell growth; Cell Proliferation - physiology; Diestrus - metabolism; Endometrium; Endometrium - metabolism; Epithelium; Estrogens; Estrogens - metabolism; Estrous Cycle - metabolism; Estrus - metabolism; Estrus cycle; Female; Glutathione Peroxidase - biosynthesis; Laboratory animals; Localization; Mice; Myometrium; Myometrium - metabolism; Nicotinamide Phosphoribosyltransferase - antagonists & inhibitors; Nicotinamide Phosphoribosyltransferase - biosynthesis; Piperidines - pharmacology; Proestrus - metabolism; Progesterone; Progesterone - metabolism; Proliferating cell nuclear antigen; Proliferating Cell Nuclear Antigen - biosynthesis; Proliferation; Steroidogenesis; Superoxide Dismutase - biosynthesis; Uterus; Visfatin
• ISSN: 0960-0760; 1879-1220
• DOI: 10.1016/j.jsbmb.2018.09.010

[Display omitted] •Visfatin is exclusively localized in luminal and glandular epithelium of the mouse uterus.•Visfatin expression is regulated in the uterus during the mouse estrous cycle.•Estrogen up regulates and progesterone down regulates visfatin expression in ovariectomized mice.•Visfatin inhibitor (FK866), up regulates PCNA and BCL2 expression in the mouse uterus.•Visfatin inhibitor (FK866) down regulates BAX and active caspase3 expression in the mouse uterus. Visfatin is an adipokine which has an endocrine effect on reproductive functions and regulates ovarian steroidogenesis. There is scant information about the expression, regulation, and functions of visfatin in the mammalian uterus. The present study examined expression and localization of visfatin in the mouse uterus at various stages of the natural estrous cycle, effects of estrogen and progesterone on localization and expression of visfatin in the ovariectomised mouse uterus and effect of visfatin inhibition by a specific inhibitor, FK866 on proliferation and apoptosis in the uterus. Western blot analysis of visfatin showed high expression in proestrus and metestrus while it declined in estrus and diestrus. Immulocalization study also showed strong immunostaining in the cells of endometrium, myometrium, luminal and glandular epithelium during proestrus and metestrus that estrus and diestrus. The uterine visfatin expression closely related to the increased estrogen levels in proestrus and suppressed when progesterone rose to a high level in diestrus. The treatment with estrogen to ovariectomised mice up-regulates visfatin, PCNA, and active caspase3 whereas progesterone up-regulates PCNA and down-regulates visfatin and active caspase3 expression in mouse uterus. The co-treatment with estrogen and progesterone up-regulates visfatin and down-regulates PCNA and active caspase3. In vitro study showed endogenous visfatin inhibition by FK866 increased expression of PCNA and BCL2 increased catalase activity while FK866 treatment decreased expression of active caspase3 and BAX with decreased SOD and GPx activity. BrdU labeling showed that inhibition of visfatin modulates the uterine proliferation. This study showed that expression of visfatin protein is steroid dependent in mouse uterus which is involved in the regulation of proliferation and apoptosis via modulating antioxidant system in the uterus of mice during the reproductive cycle.